THE THERAPEUTIC USE OF BISPHOSPHONATES

被引:50
作者
COMPSTON, JE
机构
[1] Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital
基金
英国惠康基金;
关键词
D O I
10.1136/bmj.309.6956.711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:711 / 715
页数:5
相关论文
共 27 条
[1]  
ADAMI S, 1993, OSTEOPOROSIS INT, V3, pS21
[2]   MINERALIZATION DEFECTS WITH PAMIDRONATE THERAPY FOR PAGETS-DISEASE [J].
ADAMSON, BB ;
GALLACHER, SJ ;
BYARS, J ;
RALSTON, SH ;
BOYLE, IT ;
BOYCE, BF .
LANCET, 1993, 342 (8885) :1459-1460
[3]  
ALEXANDRE C, 1990, OSTEOPOROSIS, P1441
[4]  
BONNEKAMP PM, 1986, BONE MINER, V1, P27
[5]  
BOYCE BF, 1984, LANCET, V1, P821
[6]   HRT AND OSTEOPOROSIS [J].
COMPSTON, JE .
BRITISH MEDICAL BULLETIN, 1992, 48 (02) :309-344
[7]  
FLEISCH H, 1993, OSTEOPOROSIS INT, V3, pS15
[8]   BISPHOSPHONATES - PHARMACOLOGY AND USE IN THE TREATMENT OF TUMOR-INDUCED HYPERCALCEMIC AND METASTATIC BONE-DISEASE [J].
FLEISCH, H .
DRUGS, 1991, 42 (06) :919-944
[9]   THE ADFR CONCEPT REVISITED [J].
FROST, HM .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) :349-353
[10]   INTRAVENOUS PAMIDRONATE IN THE TREATMENT OF OSTEOPOROSIS ASSOCIATED WITH CORTICOSTEROID DEPENDENT LUNG-DISEASE - AN OPEN PILOT-STUDY [J].
GALLACHER, SJ ;
FENNER, JAK ;
ANDERSON, K ;
BRYDEN, FM ;
BANHAM, SW ;
LOGUE, FC ;
COWAN, RA ;
BOYLE, IT .
THORAX, 1992, 47 (11) :932-936